Fecal Microbiota Transplantation: Tales of Caution

Sahil Khanna¹, Colleen S Kraft^{2

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
³ Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.

Editorial

Sahil Khanna et al. Clin Infect Dis. 2021.

. 2021 Jun 1;72(11):e881-e882.

doi: 10.1093/cid/ciaa1492.

Sahil Khanna¹, Colleen S Kraft^{2

3}

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
³ Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.

No abstract available

Keywords: Clostridioides difficile; adverse events; infection transmission; mirobiome; multi-drug resistance.

Comment on

Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.
Zellmer C, Sater MRA, Huntley MH, Osman M, Olesen SW, Ramakrishna B. Zellmer C, et al. Clin Infect Dis. 2021 Jun 1;72(11):e876-e880. doi: 10.1093/cid/ciaa1486. Clin Infect Dis. 2021. PMID: 33159210